Changzhou Sifary Medical Technology Co., Ltd. appears in FDA premarket notification records as the applicant for dental X-ray devices. The supplied collection holds one linked 510(k) record, K260795, decided Substantially Equivalent on 2026-09-14, and that single record is also the entire recordSample. A separate clearance, K232068, appears in the numbered sources but not in the collection snapshot. The company's own website describes it as a dental equipment and consumables manufacturer founded in 2016 in Changzhou, Jiangsu. [1][4][6]

The HyperLight-M clearance

K260795 covers a device named Hand-held Dental X-ray System (HyperLight-M), submitted by Changzhou Sifary Medical Technology Co., Ltd. with a Changzhou, Jiangsu address. FDA received the notification on 2026-03-11 and decided Substantially Equivalent on 2026-09-14 under the Traditional clearance type, with a summary statement and no third-party review. The product code is EHD, regulation number 872.1800, device class 2, advisory committee Dental. [1][9]

The decision record describes the device as substantially equivalent to its predicate, and the classification name carried in the filing data is Unit, X-Ray, Extraoral With Timer. The applicant contact listed is Qingfei Pan. The record does not describe clinical performance, dose characteristics or commercial availability. [1][8]

An earlier portable unit

A prior clearance, K232068, names the same applicant and a device called HyperLight Portable X-ray Unit, also under 21 CFR 872.1800, Class II, product code EHD. The FDA letter is dated September 1, 2023 and references a submission dated July 7, 2023. That letter states the manufacturer determined conformity with all standards and that electrical tests were performed by TÜV Rheinland (Shanghai) Co., Ltd. [4][7]

The letter lists three FDA guidance documents associated with the device, including radiation safety considerations for X-ray equipment designed for hand-held use. This clearance is not part of the supplied collection snapshot; it is documented only in the numbered sources. [4]

Product line as published by the company

The company's website, published under the Eighteeth name, lists an X-Ray Unit category containing HyperLight, HyperLight-G, HyperLight-M and HyperLight-A, alongside a CBCT product called FinScan F350 and digital sensors called NanoPix Pro and NanoPix-M Pro. The site describes HyperLight-M as a portable X-ray with sensor positioning. These are the company's own product descriptions, not FDA findings. [3]

The same site's about page states the company was founded in 2016 in Changzhou, Jiangsu, and describes it as a manufacturer of dental equipment and consumables. It reports products reaching 154 countries and regions, cooperation with more than 340 universities, a team of over 700 people, and patent applications including 53 invention patents, with a note that personnel and patent information includes holding subsidiaries. These figures are company-published and unverified here. [6]

Identity and filing scope

The FDA records identify Changzhou Sifary Medical Technology Co., Ltd. as the legal applicant; the Eighteeth name appears on the company's website as the publishing brand, and the sources do not establish a separate corporate parent. The filing address on K260795, No. 26 Yandanghe Road, Xinbei District, Changzhou, matches one of two addresses listed on the company site; a filing address is not treated here as a headquarters determination. [1][3][6]

Across the supplied collection, the single linked record carries a Substantially Equivalent decision, and the recordSample contains that same record, so the sample decision count is one of one. This is a snapshot of supplied filings, not a measure of total clearances, sales or safety performance. [1]